(Q44293732)

English

Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

Annamaria Colao

2

object named as

A Colao

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

G Lombardi

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

P Marzullo

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

B Biondi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

E Palmieri

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

S Fazio

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Multicenter Italian Study Group on Lanreotide

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

971-976

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

The role of the GH/IGF-I axis for cardiac function and structure

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Growth hormone and the heart

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Acromegalic cardiopathy improves after treatment with increasing doses of octreotide

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Growth-hormone and prolactin excess

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)

1 reference

https://api.crossref.org/works/10.1007%2FBF03344070

21 January 2018

Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arrhythmia profile in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac hypertrophy and function in asymptomatic acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal heart rate variability in adults with growth hormone deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acromegalic cardiopathy: a left ventricular scintigraphic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for cure of acromegaly: a consensus statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of octreotide on left ventricular mass in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone and the heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diurnal rhythm of plasma catecholamines in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of short-term growth hormone hypersecretion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acromegaly and cardiovascular disorders. A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired cardiac performance is a distinct feature of uncomplicated acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/12553557

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03344070

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44293732&oldid=2206548914"